Subscribe
shutterstock_436917634_eqroy
EQroy / Shutterstock.com
20 October 2020BiotechnologyMuireann Bolger

WTO fails to strike deal to waive COVID-19 IP

Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation (WTO) to conclude an agreement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott